Skip to main content

and
  1. No Access

    Article

    Skin response using NIH consensus criteria vs Hopkins scale in a phase II study for steroid-refractory chronic GVHD

    One of the obstacles to chronic GVHD research is the lack of standardized response criteria. The National Institute of Health (NIH) has recommended response criteria at a Consensus Conference. These need to be...

    D A Jacobsohn, A Rademaker, M Kaup, G B Vogelsang in Bone Marrow Transplantation (2009)

  2. Article

    Erratum: Toxic absorption of pimecrolimus in a patient with severe acute graft-versus-host disease

    Correction to: Bone Marrow Transplantation (2005) 36, 919–920. doi:10.1038/sj.bmt1705146 My attention has been drawn to the fact that the authors of this letter believed that the patient's cutaneous GvHD was t...

    D L Neuman, J E Farrar, J M Moresi, G B Vogelsang in Bone Marrow Transplantation (2006)

  3. No Access

    Article

    Toxic absorption of pimecrolimus in a patient with severe acute graft-versus-host disease

    D L Neuman, J E Farrar, J M Moresi, G B Vogelsang in Bone Marrow Transplantation (2005)

  4. No Access

    Article

    A case of retroperitoneal fibrosis in a patient following HSCT

    A Nanda, J D Rizzo, G B Vogelsang in Bone Marrow Transplantation (2005)

  5. No Access

    Article

    High incidence of graft failure in children receiving CD34+ augmented elutriated allografts for nonmalignant diseases

    T-cell depletion of the marrow graft using counterflow centrifugal elutriation reduces the risk of graft-versus-host disease (GVHD). However, because of high rates of graft failure and relapse, elutriation alo...

    C H McDonough, D A Jacobsohn, G B Vogelsang, S J Noga in Bone Marrow Transplantation (2003)